JPS5754121A - Production of substance having antiviral and carcinostatic activity - Google Patents
Production of substance having antiviral and carcinostatic activityInfo
- Publication number
- JPS5754121A JPS5754121A JP55130431A JP13043180A JPS5754121A JP S5754121 A JPS5754121 A JP S5754121A JP 55130431 A JP55130431 A JP 55130431A JP 13043180 A JP13043180 A JP 13043180A JP S5754121 A JPS5754121 A JP S5754121A
- Authority
- JP
- Japan
- Prior art keywords
- adsorbates
- adsorbent
- substance
- antiviral
- eluted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
PURPOSE: In the chromatography of blood cell constituents, a part of the adsorbates is eluted with an aqueous solution of a specific ion strength and the remaining adsorbates are separated from the adsorbent to give the titled substance.
CONSTITUTION: Blood cell constituents, which is obtained by removing cell membranes from blood cells, is subjected to chromatography using an adsorbent, preferably having capability of adsorbing acidic substances such as diethylaminoethylcellulose or diethylaminoethyl-cephadex. Then, a part of the adsorbates is eluted with an aqueous solution of 0.05M ion strength such as sodium chloride, phosphate or borate solution and the remaining adsorbates are separated frm the adsorbent and purified by means of a purification process for high polymer such as gel filtration or electrophoresis to give the objective substance having antiviral and carcinostatic activity. Blood cells may originate from any aminals such as human, horse, cattle or fowl.
COPYRIGHT: (C)1982,JPO&Japio
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP55130431A JPS5754121A (en) | 1980-09-19 | 1980-09-19 | Production of substance having antiviral and carcinostatic activity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP55130431A JPS5754121A (en) | 1980-09-19 | 1980-09-19 | Production of substance having antiviral and carcinostatic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5754121A true JPS5754121A (en) | 1982-03-31 |
Family
ID=15034067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP55130431A Pending JPS5754121A (en) | 1980-09-19 | 1980-09-19 | Production of substance having antiviral and carcinostatic activity |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5754121A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58172632A (en) * | 1982-04-01 | 1983-10-11 | Minolta Camera Co Ltd | Exposure controller of camera with zoom lens |
| US5741894A (en) * | 1995-09-22 | 1998-04-21 | Baxter International, Inc. | Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form |
-
1980
- 1980-09-19 JP JP55130431A patent/JPS5754121A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58172632A (en) * | 1982-04-01 | 1983-10-11 | Minolta Camera Co Ltd | Exposure controller of camera with zoom lens |
| US5741894A (en) * | 1995-09-22 | 1998-04-21 | Baxter International, Inc. | Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3379644D1 (en) | Adsorbent and process for preparing the same | |
| JPS57149228A (en) | Novel erythropoietin and its preparation | |
| YU87090A (en) | HIMOPAPAIN PURIFICATION PROCEDURE | |
| NZ210427A (en) | Process for purifying blood clotting factor (factor viii:c); pharmaceutical compositions | |
| ES2045669T3 (en) | PROCEDURE FOR THE PURIFICATION OF ANEXINS. | |
| FR2522324B1 (en) | PYRROLE-ACETAMIDES, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITION CONTAINING THEM | |
| JPS5754121A (en) | Production of substance having antiviral and carcinostatic activity | |
| SG72665A1 (en) | Method and composition for determining the immunological activity of bioactive substances | |
| JPS5758629A (en) | Separating and purifying method of colonization stimulating factor and callicrein in human urine | |
| JPS5781829A (en) | Urea adsorbing resin | |
| JPS5616496A (en) | Recovery of erythropoietin | |
| GB2016477A (en) | HGI-glycoprotein and isolation thereof | |
| JPS6160050B2 (en) | ||
| GB2024228A (en) | Process and adsorbent for the isolation in purer form of enzyme(s) from a crude enzyme solution | |
| Chapman et al. | Uremic middle molecules: separation and quantitation | |
| ZA845434B (en) | Complexable heterogeneous oligosaccharides and alpha-hydosanes having therapeutical activity,process for their preparation and related pharmaceutical compositions | |
| FR2549390B1 (en) | METHOD FOR RETAINING A BODY DISSOLVED IN A SOLUTION | |
| JPS5543123A (en) | Preparation of highly active heparin | |
| GB2087435B (en) | Treatment of membrane in chlor-alkali cell prior to electrolysis | |
| Ramsey et al. | Fractionation of coral snake venom: Preliminary studies on the separation and characterization of the protein fractions | |
| GB1426039A (en) | Haptoglobin in aqueous solution and process for tits preparation | |
| SU554499A1 (en) | Method for isolating mucopolysaccharides | |
| AR220276A1 (en) | PROCEDURE TO REDUCE THE METALIC ION CONCENTRATION OF AQUEOUS EFFLUENTS | |
| JPS5387400A (en) | Collection of protein | |
| JPS56140947A (en) | Production of coenzyme q |